IFLR1000

Neuland Laboratories Re1.26 million QIP issue

31/5/2018
Qualified institutional placement (QIP)
Select tab

Re 1.26 billion

$ 18.8 million

Announced

31/5/2018

Overview:

  • Neuland Laboratories has undertaken a Re1.26 million QIP issue.
  • Shares were listed on the BSE and NSE.
  • Spark Capital has acted as bookrunning lead manager.
  • The issuer is a pharmaceuticals firm, operating in 80 countries.

Katrin Kostadinova - Data analyst

Jurisdiction:

India

Deal type:

Qualified institutional placement (QIP)

Practice area:

Capital markets : Debt

Governing law:

India

Industry sector:

Pharmaceuticals and life sciences

Firm:
Luthra and Luthra Law Offices India

Party: Bookrunner (Bookrunner, Lead manager)

Related deals